tiprankstipranks
Trending News
More News >
Healthequity Inc (DE:2HE)
:2HE
Germany Market

Healthequity (2HE) Ratios

Compare
3 Followers

Healthequity Ratios

DE:2HE's free cash flow for Q4 2025 was $0.61. For the 2025 fiscal year, DE:2HE's free cash flow was decreased by $ and operating cash flow was $0.15. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
3.06 4.76 2.92 2.29 2.25
Quick Ratio
3.06 4.76 2.92 2.29 2.25
Cash Ratio
1.89 3.45 1.94 1.47 1.61
Solvency Ratio
0.19 0.18 0.11 0.07 0.09
Operating Cash Flow Ratio
2.17 2.07 1.15 0.92 0.89
Short-Term Operating Cash Flow Coverage
33.98 0.00 5.45 6.74 2.37
Net Current Asset Value
$ -855.89M$ -571.33M$ -810.37M$ -903.19M$ -871.10M
Leverage Ratios
Debt-to-Assets Ratio
0.32 0.29 0.32 0.32 0.40
Debt-to-Equity Ratio
0.52 0.46 0.52 0.54 0.78
Debt-to-Capital Ratio
0.34 0.31 0.34 0.35 0.44
Long-Term Debt-to-Capital Ratio
0.33 0.30 0.34 0.35 0.42
Financial Leverage Ratio
1.63 1.55 1.63 1.68 1.97
Debt Service Coverage Ratio
4.51 4.74 2.41 2.18 1.43
Interest Coverage Ratio
2.68 2.31 0.80 0.95 2.39
Debt to Market Cap
0.11 0.14 0.19 0.23 0.17
Interest Debt Per Share
13.46 11.55 12.35 12.57 14.95
Net Debt to EBITDA
2.41 1.87 4.32 7.60 4.82
Profitability Margins
Gross Profit Margin
64.78%62.29%56.87%56.00%56.62%
EBIT Margin
14.73%12.94%1.20%-3.99%5.32%
EBITDA Margin
28.13%28.25%19.90%13.61%21.12%
Operating Profit Margin
13.53%12.82%4.52%4.58%11.35%
Pretax Profit Margin
9.67%7.51%-4.42%-8.82%0.56%
Net Profit Margin
8.06%5.57%-3.03%-5.85%1.20%
Continuous Operations Profit Margin
8.06%5.57%-3.03%-5.85%1.20%
Net Income Per EBT
83.34%74.24%68.62%66.36%213.38%
EBT Per EBIT
71.48%58.56%-97.87%-192.69%4.97%
Return on Assets (ROA)
2.80%1.76%-0.85%-1.43%0.33%
Return on Equity (ROE)
4.57%2.74%-1.38%-2.39%0.64%
Return on Capital Employed (ROCE)
4.93%4.21%1.32%1.17%3.32%
Return on Invested Capital (ROIC)
4.10%3.11%0.89%0.77%6.84%
Return on Tangible Assets
16.23%8.20%-5.18%-9.07%1.43%
Earnings Yield
1.01%0.86%-0.51%-1.00%0.14%
Efficiency Ratios
Receivables Turnover
10.17 9.53 8.90 8.65 10.08
Payables Turnover
29.42 31.31 26.74 12.09 197.17
Inventory Turnover
0.00 0.00 371.66M 0.00 0.00
Fixed Asset Turnover
25.84 18.38 12.43 8.70 6.18
Asset Turnover
0.35 0.32 0.28 0.24 0.27
Working Capital Turnover Ratio
3.15 2.89 3.83 3.33 3.67
Cash Conversion Cycle
23.49 26.64 27.37 11.98 34.36
Days of Sales Outstanding
35.90 38.30 41.02 42.18 36.21
Days of Inventory Outstanding
0.00 0.00 <0.01 0.00 0.00
Days of Payables Outstanding
12.41 11.66 13.65 30.20 1.85
Operating Cycle
35.90 38.30 41.02 42.18 36.21
Cash Flow Ratios
Operating Cash Flow Per Share
3.91 2.84 1.78 1.70 2.45
Free Cash Flow Per Share
3.89 2.30 0.37 0.05 1.14
CapEx Per Share
0.02 0.54 1.41 1.65 1.31
Free Cash Flow to Operating Cash Flow
0.99 0.81 0.21 0.03 0.47
Dividend Paid and CapEx Coverage Ratio
163.08 5.27 1.26 1.03 1.87
Capital Expenditure Coverage Ratio
163.08 5.27 1.26 1.03 1.87
Operating Cash Flow Coverage Ratio
0.31 0.26 0.15 0.14 0.17
Operating Cash Flow to Sales Ratio
0.28 0.24 0.17 0.19 0.25
Free Cash Flow Yield
3.52%3.04%0.61%0.09%1.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
99.19 116.08 -196.55 -100.31 704.62
Price-to-Sales (P/S) Ratio
7.99 6.47 5.96 5.87 8.49
Price-to-Book (P/B) Ratio
4.54 3.18 2.71 2.40 4.51
Price-to-Free Cash Flow (P/FCF) Ratio
28.40 32.87 163.00 1.14K 73.53
Price-to-Operating Cash Flow Ratio
28.22 26.63 34.11 31.51 34.27
Price-to-Earnings Growth (PEG) Ratio
1.40 -0.37 4.73 0.19 -8.85
Price-to-Fair Value
4.54 3.18 2.71 2.40 4.51
Enterprise Value Multiple
30.82 24.77 34.27 50.75 44.99
Enterprise Value
10.40B 7.00B 5.88B 5.23B 6.97B
EV to EBITDA
30.82 24.77 34.27 50.75 44.99
EV to Sales
8.67 7.00 6.82 6.91 9.50
EV to Free Cash Flow
30.80 35.56 186.48 1.34K 82.34
EV to Operating Cash Flow
30.62 28.81 39.02 37.06 38.38
Tangible Book Value Per Share
-8.49 -5.25 -8.16 -9.22 -9.63
Shareholders’ Equity Per Share
24.35 23.78 22.45 22.28 18.57
Tax and Other Ratios
Effective Tax Rate
0.17 0.26 0.31 0.34 -1.13
Revenue Per Share
13.81 11.68 10.21 9.10 9.88
Net Income Per Share
1.11 0.65 -0.31 -0.53 0.12
Tax Burden
0.83 0.74 0.69 0.66 2.13
Interest Burden
0.66 0.58 -3.69 2.21 0.11
Research & Development to Revenue
0.20 0.22 0.22 0.21 0.17
SG&A to Revenue
0.11 0.10 0.11 0.11 0.12
Stock-Based Compensation to Revenue
0.08 0.08 0.07 0.07 0.06
Income Quality
3.51 4.36 -5.76 -3.18 20.56
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis